Insys Therapeutics (INSY) –
-
FDA Accepts New Drug Application for INSYS Therapeutics’ Naloxone Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose
-
Form 25-NSE Insys Therapeutics, Inc. Filed by: The Nasdaq Stock Market LLC
-
Insys Therapeutics (INSY) Receives Court Approval of 'First Day' Motions Related to Chapter 11 Petitions
-
INSYS Therapeutics, Inc. Receives Court Approval of “First Day” Motions
-
Form 8-K Insys Therapeutics, Inc. For: Jun 10
-
Pre-Open Movers 06/10: (PRVB) (DATA) (TLRY) Higher; (INSY) (RWLK) (ONCE) (more...)
-
Form 8-K Insys Therapeutics, Inc. For: Jun 10
-
Insys Therapeutics (INSY) Begins Chapter 11 Process to Facilitate Asset Sales and Address Legacy Liabilities
-
INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities
-
Form 8-K/A Insys Therapeutics, Inc. For: Jun 02
-
Form 4 Insys Therapeutics, Inc. For: Apr 17 Filed by: Housley Andrece
-
Form 3 Insys Therapeutics, Inc. For: Apr 17 Filed by: Housley Andrece
-
Insys Therapeutics (INSY) call put ratio 5.8 calls to 1 put with focus on June 1 and 2 calls as shares rally 44%
-
Insys Therapeutics (INSY) Quickly Pares Gain, Still Up 50%
-
Insys Therapeutics (INSY) Halted on Second LUDP
-
Insys Therapeutics (INSY) Resumes Trading, Now Up 110%
-
Insys Therapeutics (INSY) Halted on LUDP, Up 82%
-
Opioid drugmaker Insys Chairman Steven Meyer quits after settlement with DoJ
-
Form 8-K Insys Therapeutics, Inc. For: May 22
-
Form 4 Insys Therapeutics, Inc. For: Apr 17 Filed by: Long Andrew G
-
Insys Therapeutics (INSY) Agrees to Enter $225 Million Global Resolution of Criminal and Civil Investigations
-
Form 8-K Insys Therapeutics, Inc. For: May 22
-
Janney Downgrades INSYS Therapeutics (INSY) to Neutral
-
Increasing unusual call option volume: PTC TUP QID MKC JEF FITB INSY PII WCG LAZ
-
Increasing unusual option volume: JEF QID GTLS INSY LAZ
-
Pre-Open Movers 05/13: (AMBR) (CPRX) (CLRB) Higher; (WFT) (INSY) (UBER) (more...)
-
Insys Therapeutics (INSY) Plunges After Bankruptcy Warning
-
Form NT 10-Q Insys Therapeutics, Inc. For: Mar 31
-
Form 8-K Insys Therapeutics, Inc. For: May 10
-
Form 10-Q Insys Therapeutics, Inc. For: Mar 31
-
INSYS Therapeutics Reports First Quarter 2019 Results
-
Kapoor is Convicted of Plot to Drive Opioid Sales - Bloomberg
-
Form 10-K/A Insys Therapeutics, Inc. For: Dec 31
-
Form SC 13G/A Insys Therapeutics, Inc. Filed by: ETF MANAGERS GROUP, LLC
-
Form 4 Insys Therapeutics, Inc. For: Mar 04 Filed by: Mahboob Vaseem
-
Form 4 Insys Therapeutics, Inc. For: Mar 04 Filed by: BOHLEN ELIZABETH
-
Form 4 Insys Therapeutics, Inc. For: Jan 25 Filed by: Nance Mark E
-
Form 4 Insys Therapeutics, Inc. For: Apr 02 Filed by: Vanhove Geertrui
-
Form 3 Insys Therapeutics, Inc. For: Apr 02 Filed by: Vanhove Geertrui
-
Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Motahari Saeed
-
Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Long Andrew G
-
Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: MEYER STEVEN J
-
Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: LAPALME PIERRE
-
Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Vishnoi Rohit
-
Form 8-K/A Insys Therapeutics, Inc. For: Apr 14
-
Form 8-K Insys Therapeutics, Inc. For: Apr 17
-
Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Vishnoi Rohit
-
Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Long Andrew G
-
Form 4 Insys Therapeutics, Inc. For: Mar 05 Filed by: Motahari Saeed
-
Form 4 Insys Therapeutics, Inc. For: Jan 25 Filed by: Nance Mark E
Back to INSY Stock Lookup